Co-amilofruse 10mg/80mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

co-amilofruse 10mg/80mg tablets

aurobindo pharma ltd - amiloride hydrochloride; furosemide - oral tablet - 10mg ; 80mg

MORPHINE LUPIN MR morphine sulfate pentahydrate 100 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine lupin mr morphine sulfate pentahydrate 100 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - tablet, modified release - excipient ingredients: hyetellose; povidone; hypromellose; magnesium stearate; purified talc; titanium dioxide; iron oxide black; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE LUPIN MR morphine sulfate pentahydrate 10 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine lupin mr morphine sulfate pentahydrate 10 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE MR MYLAN morphine sulfate pentahydrate 100 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 100 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - tablet, modified release - excipient ingredients: hyetellose; povidone; hypromellose; magnesium stearate; purified talc; titanium dioxide; iron oxide black; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.